Canton Hathaway »

Vaneck Vectors Pharmaceutical etf shares owned by Canton Hathaway

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Canton Hathaway from 13F filings

Historical chart of Canton Hathaway investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Canton Hathaway consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Canton Hathaway

Quarter filed Position value Share count Share price at filing
2025-09-30 $904k 10k 90.40
2025-06-30 $880k 10k 88.00
2025-03-31 $911k 10k 91.10

More positions owned by Canton Hathaway

Berkshire Hathaway (BRK.A)
Vanguard 500 ETF Etf (VOO)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Etf (GLD)
Ishares Msci Eafe Etf Etf (EFA)
Berkshire Hathaway (BRK.B)
Alphabet Inc Class C cs (GOOG)
Amazon (AMZN)
Qxo (QXO)
iShares Silver Trust Etf (SLV)
Apple (AAPL)
Bloom Energy Corp (BE)
NVIDIA Corporation (NVDA)
Industrial Select SPDR ETF Etf (XLI)
JPMorgan Chase & Co. (JPM)

View all positions for Canton Hathaway

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf